ICUI vs. LRCX
ICUI (ICU Medical, Inc.) and LRCX (Lam Research Corporation) are both stocks. ICUI operates in Medical Instruments & Supplies (Healthcare), while LRCX operates in Semiconductor Equipment & Materials (Technology). Over the past 10 years, ICUI returned 2.23%/yr vs 47.12%/yr for LRCX. At a 0.23 correlation, their price movements are largely independent.
Performance
ICUI vs. LRCX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ICUI achieves a -8.52% return, which is significantly lower than LRCX's 101.03% return. Over the past 10 years, ICUI has underperformed LRCX with an annualized return of 2.23%, while LRCX has yielded a comparatively higher 47.12% annualized return.
ICUI
- 1D
- 0.03%
- 1M
- 9.99%
- YTD
- -8.52%
- 6M
- -9.39%
- 1Y
- -0.02%
- 3Y*
- -10.89%
- 5Y*
- -8.71%
- 10Y*
- 2.23%
LRCX
- 1D
- 2.78%
- 1M
- 32.93%
- YTD
- 101.03%
- 6M
- 115.41%
- 1Y
- 313.85%
- 3Y*
- 79.31%
- 5Y*
- 40.79%
- 10Y*
- 47.12%
ICUI vs. LRCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ICUI ICU Medical, Inc. | -8.52% | -8.06% | 55.57% | -36.66% | -33.65% | 10.65% | 14.63% | -18.51% | 6.31% | 46.59% |
LRCX Lam Research Corporation | 101.03% | 139.16% | -6.84% | 88.63% | -40.72% | 53.66% | 64.18% | 119.33% | -24.40% | 76.21% |
Correlation
The correlation between ICUI and LRCX is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Apr 1, 1992 | 0.23 |
Fundamentals
ICUI:
$3.29B
LRCX:
$434.03B
ICUI:
$1.89
LRCX:
$5.29
ICUI:
68.99
LRCX:
65.00
ICUI:
1.62
LRCX:
4.92
ICUI:
1.50
LRCX:
20.11
ICUI:
1.56
LRCX:
41.01
ICUI:
$2.16B
LRCX:
$21.68B
ICUI:
$817.30M
LRCX:
$10.84B
ICUI:
$247.33M
LRCX:
$6.10B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ICUI vs. LRCX — Risk / Return Rank
ICUI
LRCX
ICUI vs. LRCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ICU Medical, Inc. (ICUI) and Lam Research Corporation (LRCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ICUI | LRCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.00 | 6.34 | -6.34 |
Sortino ratioReturn per unit of downside risk | 0.26 | 5.04 | -4.78 |
Omega ratioGain probability vs. loss probability | 1.03 | 1.67 | -0.64 |
Calmar ratioReturn relative to maximum drawdown | -0.00 | 15.81 | -15.81 |
Martin ratioReturn relative to average drawdown | -0.00 | 53.72 | -53.72 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ICUI | LRCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.00 | 6.34 | -6.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.21 | 0.89 | -1.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.06 | 1.06 | -1.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.44 | -0.20 |
Drawdowns
ICUI vs. LRCX - Drawdown Comparison
The maximum ICUI drawdown since its inception was -73.82%, smaller than the maximum LRCX drawdown of -87.90%. Use the drawdown chart below to compare losses from any high point for ICUI and LRCX.
Loading charts...
Drawdown Indicators
| ICUI | LRCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -73.82% | -87.90% | +14.08% |
Max Drawdown (1Y)Largest decline over 1 year | -27.18% | -20.01% | -7.17% |
Max Drawdown (3Y)Largest decline over 3 years | -58.22% | -47.10% | -11.12% |
Max Drawdown (5Y)Largest decline over 5 years | -68.82% | -56.39% | -12.43% |
Max Drawdown (10Y)Largest decline over 10 years | -73.82% | -56.39% | -17.43% |
Current DrawdownCurrent decline from peak | -57.86% | 0.00% | -57.86% |
Average DrawdownAverage peak-to-trough decline | -25.75% | -28.19% | +2.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.14% | 5.87% | +6.27% |
Volatility
ICUI vs. LRCX - Volatility Comparison
The current volatility for ICU Medical, Inc. (ICUI) is 10.04%, while Lam Research Corporation (LRCX) has a volatility of 16.14%. This indicates that ICUI experiences smaller price fluctuations and is considered to be less risky than LRCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ICUI | LRCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.04% | 16.14% | -6.10% |
Volatility (6M)Calculated over the trailing 6-month period | 23.98% | 40.20% | -16.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.17% | 49.88% | -12.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.89% | 45.94% | -5.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.45% | 44.58% | -7.13% |
Dividends
ICUI vs. LRCX - Dividend Comparison
ICUI has not paid dividends to shareholders, while LRCX's dividend yield for the trailing twelve months is around 0.29%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICUI ICU Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LRCX Lam Research Corporation | 0.29% | 0.57% | 1.19% | 0.95% | 1.53% | 0.78% | 1.04% | 1.54% | 2.79% | 1.01% | 1.28% | 1.36% |
Financials
ICUI vs. LRCX - Financials Comparison
This section allows you to compare key financial metrics between ICU Medical, Inc. and Lam Research Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ICUI vs. LRCX - Profitability Comparison
ICUI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ICU Medical, Inc. reported a gross profit of 206.23M and revenue of 530.23M. Therefore, the gross margin over that period was 38.9%.
LRCX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lam Research Corporation reported a gross profit of 2.91B and revenue of 5.84B. Therefore, the gross margin over that period was 49.8%.
ICUI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ICU Medical, Inc. reported an operating income of 13.58M and revenue of 530.23M, resulting in an operating margin of 2.6%.
LRCX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lam Research Corporation reported an operating income of 2.05B and revenue of 5.84B, resulting in an operating margin of 35.0%.
ICUI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ICU Medical, Inc. reported a net income of 30.74M and revenue of 530.23M, resulting in a net margin of 5.8%.
LRCX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lam Research Corporation reported a net income of 1.83B and revenue of 5.84B, resulting in a net margin of 31.3%.
Frequently Asked Questions
ICUI and LRCX have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LRCX has higher volatility (16.14%) compared to ICUI (10.04%). In terms of maximum drawdown, ICUI dropped -73.82% vs LRCX's -87.90%.
LRCX currently has the higher Sharpe Ratio (6.34 vs -0.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ICUI and LRCX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer